PETER OPPELT, MD
Medical Oncology Physician · SAINT LOUIS, MO
Individual Active NPI 1639332968
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 629 | 104,212 | $8,554,627 | $3,008,834 | $2,390,393 |
| 2023 | 860 | 217,834 | $15,820,154 | $5,286,407 | $4,201,488 |
| 2022 | 789 | 135,985 | $10,137,946 | $3,468,603 | $2,765,434 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9299 | Injection, nivolumab, 1 mg | 13,740 | $30 | $24 |
| J9271 | Injection, pembrolizumab, 1 mg | 12,800 | $53 | $43 |
| J1453 | Injection, fosaprepitant, 1 mg | 6,900 | $0 | $0 |
| J0461 | Injection, atropine sulfate, 0.01 mg | 2,210 | $0 | $0 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,930 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 1,620 | $25 | $20 |
| Q5115 | Injection, rituximab-abbs, biosimilar, (truxima), 10 mg | 1,420 | $32 | $26 |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 1,270 | $48 | $38 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 1,010 | $1 | $1 |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | 640 | $0 | $0 |
| J9190 | Injection, fluorouracil, 500 mg | 559 | $3 | $2 |
| J0640 | Injection, leucovorin calcium, per 50 mg | 555 | $5 | $4 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | 2015014057 | MO |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Missouri
- NPI 1023206158
- NPI 1043697063
- NPI 1881049187
- NPI 1215953534
- NPI 1528181997
- NPI 1740488766
- NPI 1710115951
- NPI 1700267986
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.